documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
2,115 rows where document_type = "Notice" and posted_year = 2023 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA_FRDOC_0001-30344 | EPA | EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T13:38:49Z | 2023-28749 | 0 | 0 | 0900006486365be4 | ||
| EPA-HQ-OPP-2023-0597-0001 | EPA | EPA-HQ-OPP-2023-0597 | Exemption: Clothianidin | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2024-01-17T04:59:59Z | 2024-01-17T02:01:01Z | 2023-28772 | 0 | 0 | 0900006486365b43 | |
| EPA-HQ-ORD-2012-0830-0100 | EPA | EPA-HQ-ORD-2012-0830 | Availability of the Benchmark Dose (BMD) Model Code and BMD Modeling Output Files for the Draft Integrated Risk Information System (IRIS) Toxicological Review of Inorganic Arsenic | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2024-01-17T04:59:59Z | 2024-01-18T02:00:45Z | 2023-28766 | 0 | 0 | 0900006486365bde | |
| FWS-R8-ES-2023-0191-0001 | FWS | Receipt of Proposed Habitat Conservation Plan for Seven Species; Sacramento Municipal Utility District, Sacramento County, CA; Draft Environmental Assessment FWS-R8-ES-2023-0191 | Draft Habitat Conservation Plan and Draft Environmental Assessment; Sacramento Municipal Utility District Operations, Maintenance, and New Construction Habitat Conservation Plan, Sacramento County, CA | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2024-01-30T04:59:59Z | 2024-01-30T02:00:37Z | 2023-28719 | 0 | 0 | 0900006486365625 | |
| EPA-HQ-OA-2013-0320-0031 | EPA | Technical Guidance for Assessing Environmental Justice in Regulatory Analysis EPA-HQ-OA-2013-0320 | Guidance: Assessing Environmental Justice in Regulatory Analysis | Notice | Extension of Comment Period | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T15:37:42Z | 2023-28598 | 0 | 0 | 0900006486361790 | ||
| EPA-HQ-OW-2015-0680-0423 | EPA | EPA-HQ-OW-2015-0680 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Use of Lead Free Pipes, Fittings, Fixtures, Solder and Flux for Drinking Water (Renewal) | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:01:47Z | 2023-28640 | 0 | 0 | 0900006486361660 | |
| EPA-HQ-OLEM-2023-0244-0002 | EPA | Hazardous and Solid Waste Management System: Disposal of Coal Combustion Residuals (CCR) EPA-HQ-OLEM-2023-0244 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Disposal of Coal Combustion Residuals From Electric Utilities (Renewal) | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:15:36Z | 2023-28639 | 0 | 0 | 090000648636172c | |
| EPA-HQ-OW-2017-0300-1915 | EPA | EPA-HQ-OW-2017-0300 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Lead and Copper Rule Revisions | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:24:27Z | 2023-28641 | 0 | 0 | 0900006486361915 | |
| EPA-HQ-OPPT-2015-0436-0042 | EPA | EPA-HQ-OPPT-2015-0436 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions From Testing Requirements (Renewal) | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:09:11Z | 2023-28663 | 0 | 0 | 09000064863616e9 | |
| FDA-2021-N-0039-0002 | FDA | FDA-2021-N-0039 | Electronic Submissions; Update to the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical Specification | Notice | Notice of Availability | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-11-12T06:21:06Z | 2023-28594 | 1 | 0 | 090000648636182b | |
| FDA-2023-D-4177-0021 | FDA | FDA-2023-D-4177 | Quality Considerations for Topical Ophthalmic Drug Products; Revised Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T15:10:09Z | 2023-28595 | 0 | 0 | 090000648636165b | |
| FDA-2023-D-4299-0001 | FDA | FDA-2023-D-4299 | Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T16:34:21Z | 2023-28596 | 0 | 0 | 090000648636182c | |
| FDA-2023-D-5408-0001 | FDA | FDA-2023-D-5408 | Reformulating Drug Products That Contain Carbomers Manufactured With Benzene; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T16:02:50Z | 2023-28675 | 0 | 0 | 090000648636165e | |
| USDA_FRDOC_0001-2953 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T13:31:28Z | 2023-28576 | 0 | 0 | 090000648636165c | ||
| USDA-2022-0010-0002 | USDA | Agency Information Collection Activities; USDA Generic Solution for Solicitation for Funding Opportunity Announcement USDA-2022-0010 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Funding Opportunity | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-02-27T04:59:59Z | 2024-06-05T13:16:38Z | 2023-28571 | 0 | 0 | 09000064863616ae | |
| APHIS-2023-0022-3038 | APHIS | Movement of Organisms Modified or Produced through Genetic Engineering; Notice of Exemptions APHIS-2023-0022 | Exemption: Movement of Organisms Modified or Produced through Genetic Engineering | Notice | Availability of Document | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-28T14:11:52Z | 2023-28545 | 0 | 0 | 090000648635c4e3 | ||
| EPA-HQ-OPP-2023-0074-0006 | EPA | EPA-HQ-OPP-2023-0074 | Cancellation Order for Certain Pesticide Registrations and Amendments to Terminate Uses | Notice | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2023-12-27T21:20:01Z | 2023-28547 | 0 | 0 | 090000648635c583 | ||
| EPA-HQ-OPP-2023-0075-0006 | EPA | EPA-HQ-OPP-2023-0075 | Product Cancellation Order for Certain Pesticide Registrations | Notice | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2023-12-27T17:08:40Z | 2023-28557 | 0 | 0 | 090000648635c4e5 | ||
| FDA-2022-E-0931-0005 | FDA | FDA-2022-E-0931 | Determination of Regulatory Review Period for Purposes of Patent Extension; ZOKINVY | Notice | Determinations | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2024-06-25T03:59:59Z | 2024-06-25T01:00:33Z | 2023-28511 | 0 | 0 | 090000648635c4ea |
| FDA-2023-F-5500-0001 | FDA | FDA-2023-F-5500 | Kemin Industries, Inc.; Filing of Food Additive Petition (Animal Use); Chromium Propionate; Correction. | Notice | Correction | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2023-12-29T15:38:50Z | 2023-28512 | 0 | 0 | 090000648635c3a9 | |
| FDA-2023-F-2415-0004 | FDA | FDA-2023-F-2415 | Kemin Industries, Inc.; Filing of Food Additive Petition (Animal Use); Chromium Propionate; Correction. | Notice | Correction | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2023-12-29T15:48:26Z | 2023-28512 | 0 | 0 | 090000648635d693 | |
| FDA-2022-E-0936-0005 | FDA | FDA-2022-E-0936 | Determination of Regulatory Review Period for Purposes of Patent Extension; ZOKINVY | Notice | Determinations | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2024-06-25T03:59:59Z | 2023-12-27T15:24:10Z | 2023-28511 | 0 | 0 | 090000648635c012 |
| FDA-2022-E-2225-0005 | FDA | FDA-2022-E-2225 | Determination of Regulatory Review Period for Purposes of Patent Extension; SCEMBLIX | Notice | Determinations | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2024-06-25T03:59:59Z | 2023-12-27T14:50:39Z | 2023-28519 | 0 | 0 | 090000648635c3e9 |
| FDA-2022-E-2035-0004 | FDA | FDA-2022-E-2035 | Determination of Regulatory Review Period for Purposes of Patent Extension; PONVORY | Notice | Determinations | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2024-06-25T03:59:59Z | 2023-12-27T15:44:15Z | 2023-28509 | 0 | 0 | 090000648635c5cc |
| FDA-2022-E-0926-0005 | FDA | FDA-2022-E-0926 | Determination of Regulatory Review Period for Purposes of Patent Extension; CYTALUX | Notice | Determinations | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2024-06-25T03:59:59Z | 2024-06-15T01:00:26Z | 2023-28507 | 0 | 0 | 090000648635c493 |
| FWS-HQ-IA-2023-0253-0001 | FWS | Foreign Endangered Species; Receipt of Permit Applications FWS-HQ-IA-2023-0253 | Foreign Endangered Species; Receipt of Permit Applications | Notice | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2024-01-27T04:59:59Z | 2024-01-27T02:00:33Z | 2023-28470 | 0 | 0 | 090000648635ae7f | |
| USDA_FRDOC_0001-2952 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Hearings, Meetings, Proceedings, etc.: Codex Committee on Food Hygiene | Notice | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2023-12-27T13:22:10Z | 2023-28533 | 0 | 0 | 090000648635c5c3 | ||
| EPA-HQ-OLEM-2023-0451-0001 | EPA | The Waste Reduction Model (WARM) v16 EPA-HQ-OLEM-2023-0451 | Waste Reduction Model (WARM) Version 16 | Notice | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2024-02-10T04:59:59Z | 2024-02-17T02:00:59Z | 2023-28342 | 0 | 0 | 0900006486359866 | |
| EPA-HQ-OPPT-2023-0312-0001 | EPA | EPA-HQ-OPPT-2023-0312 | 4,4′-Methylene bis(2-chloroaniline); Request Under the Toxic Substances Control Act (TSCA) for Records and Reports of Significant Adverse Reactions to Health or the Environment | Notice | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-26T13:49:05Z | 2023-28299 | 0 | 0 | 0900006486359e19 | ||
| EPA-HQ-OPP-2023-0474-0016 | EPA | EPA-HQ-OPP-2023-0474 | Endocrine Disruptor Screening Program: Near-Term Strategies for Implementation; Correction | Notice | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-27T16:56:55Z | 2023-28510 | 0 | 0 | 0900006486359e9b | ||
| EPA-HQ-OPPT-2023-0351-0001 | EPA | EPA-HQ-OPPT-2023-0351 | Definition of Lead-Based Paint Joint Virtual Workshop; Notice of Public Meeting and Request for Comments | Notice | Meeting | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2024-07-01T03:59:59Z | 2024-07-01T01:01:01Z | 2023-14682 | 0 | 0 | 0900006485c8bdc2 |
| EPA-HQ-OAR-2023-0292-0001 | EPA | California Air Resources Board ACCII Waiver Request EPA-HQ-OAR-2023-0292 | Hearings, Meetings, Proceedings, etc.: California State Motor Vehicle Pollution Control Standards; Advanced Clean Cars II Regulations; Request for Waiver of Preemption | Notice | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2024-02-28T04:59:59Z | 2024-06-12T01:01:02Z | 2023-28301 | 0 | 0 | 09000064863598dd | |
| EPA-HQ-OPPT-2023-0613-0001 | EPA | EPA-HQ-OPPT-2023-0613 | Formaldehyde; Draft Risk Evaluation Peer Review by the Science Advisory Committee on Chemicals (SACC); Request for Nominations of ad hoc Expert Reviewers | Notice | Request for Nominations | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-26T13:40:58Z | 2023-28430 | 0 | 0 | 09000064863598a5 | |
| EPA-HQ-OPPT-2017-0127-0005 | EPA | EPA-HQ-OPPT-2017-0127 | 2023 Report; Inventory of Mercury Supply, Use, and Trade in the United States; Notice of Availability | Notice | Notice of Data Availability | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-26T13:55:13Z | 2023-28376 | 0 | 0 | 0900006486359f22 | |
| FDA-2015-D-2818-0044 | FDA | FDA-2015-D-2818 | Rare Diseases: Considerations for the Development of Drugs and Biological Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-26T14:43:28Z | 2023-28310 | 0 | 0 | 0900006486359d43 | |
| FWS-R7-ES-2023-0209-0001 | FWS | Marine Mammals; Incidental Take During Specified Activities; Proposed Incidental Harassment Authorization for the Southern Beaufort Sea Stock of Polar Bears on the North Slope of Alaska FWS-R7-ES-2023-0209 | Proposed Incidental Harassment Authorization for the Southern Beaufort Sea Stock of Polar Bears on the North Slope of Alaska | Notice | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2024-01-26T04:59:59Z | 2024-02-06T02:00:38Z | 2023-28428 | 0 | 0 | 0900006486359708 | |
| USDA_FRDOC_0001-2949 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-26T13:20:54Z | 2023-28379 | 0 | 0 | 0900006486359754 | ||
| USDA_FRDOC_0001-2950 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-26T13:22:12Z | 2023-28334 | 0 | 0 | 0900006486359d70 | ||
| EPA-HQ-OPPT-2023-0061-0027 | EPA | EPA-HQ-OPPT-2023-0061 | Certain New Chemicals: Status Information for November 2023 | Notice | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2024-01-23T04:59:59Z | 2023-12-25T02:00:16Z | 2023-28240 | 0 | 0 | 0900006486351183 | |
| EPA-HQ-OPPT-2003-0004-0142 | EPA | EPA-HQ-OPPT-2003-0004 | Access to Confidential Business Information by CGI Federal Inc. | Notice | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2024-03-15T18:59:22Z | 2023-28172 | 0 | 0 | 0900006486351112 | ||
| EPA-HQ-OPP-2023-0476-0001 | EPA | EPA-HQ-OPP-2023-0476 | Pesticide Registration: Establishment of the Vector Expedited Review Voucher Program | Notice | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2023-12-22T16:07:09Z | 2023-28211 | 0 | 0 | 09000064863512a3 | ||
| EPA_FRDOC_0001-30317 | EPA | EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2023-12-22T13:12:30Z | 2023-28249 | 0 | 0 | 0900006486351219 | ||
| FDA-2023-N-2986-0003 | FDA | FDA-2023-N-2986 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:21:53Z | 2023-28290 | 0 | 0 | 0900006486351613 | ||
| FDA-1997-D-0444-0037 | FDA | Guidance of Animal Drugs for Minor Uses & Minor Species FDA-1997-D-0444 | Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T15:18:01Z | 2023-28287 | 0 | 0 | 090000648635114c | ||
| FDA-2023-D-5259-0001 | FDA | FDA-2023-D-5259 | Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T15:36:56Z | 2023-28210 | 0 | 0 | 0900006486351218 | ||
| FDA-2023-N-1157-0004 | FDA | FDA-2023-N-1157 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-04T22:17:54Z | 2023-28290 | 0 | 0 | 0900006486351117 | ||
| FDA-2013-N-1119-0018 | FDA | FDA-2013-N-1119 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:21:11Z | 2023-28290 | 0 | 0 | 0900006486351612 | ||
| FDA-2020-N-0908-0008 | FDA | FDA-2020-N-0908 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:14:23Z | 2023-28290 | 0 | 0 | 0900006486351564 | ||
| FDA-2022-D-0814-0008 | FDA | FDA-2022-D-0814 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:15:19Z | 2023-28290 | 0 | 0 | 0900006486351565 | ||
| FDA-2019-E-3287-0004 | FDA | FDA-2019-E-3287 | Determination of Regulatory Review Period for Purposes of Patent Extension; Copiktra | Notice | Determinations | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2024-02-21T04:59:59Z | 2023-12-22T15:41:59Z | 2023-28244 | 0 | 0 | 090000648635121b |
| FDA-2021-D-0548-0036 | FDA | FDA-2021-D-0548 | Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T15:08:44Z | 2023-28291 | 0 | 0 | 0900006486351145 | ||
| FDA-2019-E-3017-0004 | FDA | FDA-2019-E-3017 | Determination of Regulatory Review Period for Purposes of Patent Extension; Emgality | Notice | Determinations | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2024-02-21T04:59:59Z | 2023-12-22T14:20:59Z | 2023-28233 | 0 | 0 | 0900006486351116 |
| FDA-2023-N-1189-0004 | FDA | FDA-2023-N-1189 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:26:13Z | 2023-28290 | 0 | 0 | 09000064863516f6 | ||
| FDA-2023-N-1006-0004 | FDA | FDA-2023-N-1006 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:17:34Z | 2023-28290 | 0 | 0 | 090000648635160e | ||
| FDA-2021-D-1128-0065 | FDA | FDA-2021-D-1128 | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations; Guidance for Industry, Investigators, and Other Stakeholders; Availability | Notice | Notice of Availability | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T15:30:51Z | 2023-28262 | 0 | 0 | 0900006486351187 | ||
| FDA-2023-N-1661-0002 | FDA | FDA-2023-N-1661 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:20:18Z | 2023-28290 | 0 | 0 | 0900006486351611 | ||
| FDA-2023-N-1272-0005 | FDA | FDA-2023-N-1272 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:24:27Z | 2023-28290 | 0 | 0 | 0900006486351615 | ||
| FDA-2022-D-0745-0014 | FDA | FDA-2022-D-0745 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:16:39Z | 2023-28290 | 0 | 0 | 090000648635160d | ||
| FDA-2023-N-2286-0003 | FDA | FDA-2023-N-2286 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:19:03Z | 2023-28290 | 0 | 0 | 0900006486351610 | ||
| FDA-2023-N-2030-0005 | FDA | FDA-2023-N-2030 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:25:22Z | 2023-28290 | 0 | 0 | 0900006486351616 | ||
| FDA-2022-D-0109-0016 | FDA | FDA-2022-D-0109 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:13:11Z | 2023-28290 | 0 | 0 | 0900006486351562 | ||
| FDA-2021-D-1146-0042 | FDA | FDA-2021-D-1146 | Real-World Data: Assessing Registries To Support Regulatory Decision-Making for Drug and Biological Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T15:24:04Z | 2023-28289 | 0 | 0 | 090000648635117e | ||
| FDA-2009-N-0582-0129 | FDA | FDA-2009-N-0582 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:23:07Z | 2023-28290 | 0 | 0 | 0900006486351614 | ||
| FDA-2023-N-1053-0004 | FDA | FDA-2023-N-1053 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2023-12-22T05:00:00Z | 2023 | 12 | 2024-01-08T13:18:22Z | 2023-28290 | 0 | 0 | 090000648635160f | ||
| USDA_FRDOC_0001-2948 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Hearings, Meetings, Proceedings etc.: Codex Alimentarius Commission, Committee on Fats and Oils | Notice | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2023-12-22T13:12:16Z | 2023-28269 | 0 | 0 | 09000064863511c8 | ||
| USDA_FRDOC_0001-2947 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2023-12-22T05:00:00Z | 2023 | 12 | 2023-12-22T05:00:00Z | 2023-12-22T13:12:01Z | 2023-28171 | 0 | 0 | 090000648635114b | ||
| EPA-HQ-OPP-2019-0188-0005 | EPA | EPA-HQ-OPP-2019-0188 | RTI International and ToxStrategies LLC; Transfer of Data (December 2023) | Notice | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2023-12-21T17:44:20Z | 2023-28088 | 0 | 0 | 090000648634dc43 | ||
| FDA-2022-E-2013-0004 | FDA | FDA-2022-E-2013 | Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV | Notice | Determinations | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2024-02-21T04:59:59Z | 2023-12-21T14:39:34Z | 2023-28094 | 0 | 0 | 090000648634dc9c |
| FDA-2022-E-2011-0004 | FDA | FDA-2022-E-2011 | Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV | Notice | Determinations | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2024-02-21T04:59:59Z | 2023-12-21T15:32:46Z | 2023-28094 | 0 | 0 | 090000648634e3d5 |
| FDA-2022-E-2012-0004 | FDA | FDA-2022-E-2012 | Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV | Notice | Determinations | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2024-02-21T04:59:59Z | 2023-12-21T15:40:37Z | 2023-28094 | 0 | 0 | 090000648634e3d6 |
| FDA-2022-E-2010-0004 | FDA | FDA-2022-E-2010 | Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV | Notice | Determinations | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2024-02-21T04:59:59Z | 2023-12-21T15:29:45Z | 2023-28094 | 0 | 0 | 090000648634e3d4 |
| FDA-2020-D-1136-0084 | FDA | FDA-2020-D-1136 | Development of Monoclonal Antibody Products Targeting SARS–CoV–2 for Emergency Use Authorization; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T16:06:18Z | 2023-28092 | 0 | 0 | 090000648634e184 | ||
| FDA-2016-D-2565-0029 | FDA | FDA-2016-D-2565 | 510(k) Third Party Review Program and Third Party Emergency Use Authorization (EUA) Review; Draft Guidance for Industry, Food and Drug Administration Staff, and Third Party Review Organizations; Availability | Notice | Notice of Availability | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T17:23:07Z | 2023-28095 | 0 | 0 | 090000648634e286 | ||
| FDA-2022-E-2009-0004 | FDA | FDA-2022-E-2009 | Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV | Notice | Determinations | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2024-02-21T04:59:59Z | 2023-12-21T15:26:24Z | 2023-28094 | 0 | 0 | 090000648634e3d3 |
| FDA-2023-N-4201-0001 | FDA | FDA-2023-N-4201 | Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Implied Claims in Direct-to-Consumer Prescription Drug Promotion | Notice | 60 Day Proposed Information Collection | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2024-02-21T04:59:59Z | 2024-02-21T02:00:37Z | 2023-28093 | 0 | 0 | 090000648634dc45 |
| USDA_FRDOC_0001-2946 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2023-12-21T13:45:06Z | 2023-28086 | 0 | 0 | 090000648634e232 | ||
| FDA-2023-N-5020-0001 | FDA | FDA-2023-N-5020 | Notice to Public of Website Location of the Office of the Chief Scientist Proposed Guidance Development List | Notice | General Notice | 2023-12-20T05:00:00Z | 2023 | 12 | 2023-12-20T05:00:00Z | 2025-01-24T02:01:16Z | 2023-27967 | 1 | 0 | 090000648634bbbc | |
| USDA_FRDOC_0001-2945 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2023-12-20T05:00:00Z | 2023 | 12 | 2023-12-20T05:00:00Z | 2023-12-20T13:25:56Z | 2023-27888 | 0 | 0 | 090000648634ba38 | ||
| EPA-R09-OW-2023-0623-0006 | EPA | EPA-R09-OW-2023-0623 | CTV I 26R Public Notice (Spanish) | Notice | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2024-03-21T03:59:59Z | 2024-08-03T19:46:07Z | 0 | 0 | 09000064863483a0 | ||
| EPA-HQ-OPP-2023-0070-0009 | EPA | EPA-HQ-OPP-2023-0070 | Pesticide Product Registration: Applications for New Active Ingredients | Notice | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T15:23:49Z | 2023-27773 | 0 | 0 | 0900006486346c1f | |||
| EPA_FRDOC_0001-30302 | EPA | EPA_FRDOC_0001 | Hearings, Meetings, Proceedings etc.: Science Advisory Board Inorganic Arsenic Review Panel | Notice | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-19T13:21:40Z | 2023-27828 | 0 | 0 | 0900006486346c21 | ||
| EPA-HQ-OPP-2023-0557-0001 | EPA | EPA-HQ-OPP-2023-0557 | Pesticide Product Registration: Applications for New Active Ingredients | Notice | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2024-01-19T04:59:59Z | 2024-01-17T02:00:33Z | 2023-27773 | 0 | 0 | 09000064863470a1 | |
| EPA-R09-OW-2023-0623-0005 | EPA | EPA-R09-OW-2023-0623 | CTV I 26R Public Notice (English) | Notice | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2024-03-21T03:59:59Z | 2024-08-03T23:24:44Z | 0 | 0 | 090000648634839f | ||
| EPA-HQ-OPP-2023-0558-0001 | EPA | EPA-HQ-OPP-2023-0558 | Pesticide Product Registration: Applications for New Active Ingredients | Notice | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2024-01-19T04:59:59Z | 2024-02-08T02:00:52Z | 2023-27773 | 0 | 0 | 090000648634724f | |
| FDA-2023-D-1716-0053 | FDA | FDA-2023-D-1716 | Registration and Listing of Cosmetic Product Facilities and Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-19T15:33:24Z | 2023-27649 | 0 | 0 | 0900006486346b66 | |
| FDA-2023-P-4596-0004 | FDA | FDA-2023-P-4596 | Determination That MEPHYTON (Phytonadione) Tablets, 5 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-19T16:46:30Z | 2023-27858 | 0 | 0 | 0900006486346c55 | |
| FDA-2023-N-5431-0001 | FDA | FDA-2023-N-5431 | Hospira, Inc., et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications | Notice | Withdrawal | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-19T16:19:50Z | 2023-27853 | 0 | 0 | 0900006486346be7 | |
| FDA-2023-D-4395-0001 | FDA | FDA-2023-D-4395 | Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Devices, Draft Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-19T16:31:03Z | 2023-27852 | 0 | 0 | 0900006486346c20 | |
| FDA-2023-N-2080-0002 | FDA | FDA-2023-N-2080 | Jeremy Walenty: Final Debarment Order | Notice | Statutory Debarment | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-20T04:59:59Z | 2024-11-12T06:22:14Z | 2023-27855 | 1 | 0 | 0900006486346be3 |
| FDA-2009-N-0026-0005 | FDA | FDA-2009-N-0026 | Apothecon, et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated New Drug Applications; Correction | Notice | Correction | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-19T15:58:07Z | 2023-27859 | 0 | 0 | 0900006486346ba5 | |
| FDA-2023-N-2058-0002 | FDA | FDA-2023-N-2058 | James Funaro: Final Debarment Order | Notice | Statutory Debarment | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-20T04:59:59Z | 2024-11-12T06:22:13Z | 2023-27854 | 1 | 0 | 0900006486346ba7 |
| USDA_FRDOC_0001-2944 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2023-12-19T13:21:37Z | 2023-27845 | 0 | 0 | 0900006486346c1e | ||
| EPA-HQ-OPPT-2023-0601-0002 | EPA | EPA-HQ-OPPT-2023-0601 | Initiation of Prioritization Under the Toxic Substances Control Act (TSCA) | Notice | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-18T05:00:00Z | 2024-03-19T03:59:59Z | 2024-04-09T01:00:51Z | 2023-27641 | 0 | 0 | 090000648634394a | |
| FDA-2023-N-5344-0001 | FDA | FDA-2023-N-5344 | Pharmacyclics LLC.; Withdrawal of Approval of Indications for Mantle Cell Lymphoma and Marginal Zone Lymphoma for IMBRUVICA (ibrutinib) Capsules and Tablets | Notice | Withdrawal | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-18T05:00:00Z | 2023-12-18T14:30:13Z | 2023-27662 | 0 | 0 | 09000064863439f9 | |
| FDA-2023-D-3740-0001 | FDA | FDA-2023-D-3740 | Priority Zoonotic Animal Drug Designation and Review Process; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-18T05:00:00Z | 2023-12-18T14:17:53Z | 2023-27655 | 0 | 0 | 0900006486343903 | |
| FDA-2023-N-5323-0001 | FDA | FDA-2023-N-5323 | Hoffmann-La Roche, Inc., et al.; Withdrawal of Approval of Two New Drug Applications | Notice | Withdrawal | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-18T05:00:00Z | 2023-12-18T14:31:47Z | 2023-27661 | 0 | 0 | 0900006486343a3b | |
| FDA-2023-N-0795-0007 | FDA | FDA-2023-N-0795 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising | Notice | 30 Day Proposed Information Collection | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-18T05:00:00Z | 2024-01-18T04:59:59Z | 2024-01-17T02:00:34Z | 2023-27652 | 0 | 0 | 090000648634394b |
| FWS-R4-ES-2023-0198-0005 | FWS | Receipt of Proposed Habitat Conservation Plan for Florida Scrub-Jay and Sand Skink; Founders Ridge, Lake County, FL; Categorical Exclusion FWS-R4-ES-2023-0198 | Three Incidental Permit Applications and Proposed Habitat Conservation Plans; Lake, Volusia, and Orange Counties, FL; Reopening of Comment Periods | Notice | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-08T05:00:00Z | 2024-01-09T04:59:59Z | 2023-12-18T21:06:36Z | 0 | 0 | 0900006486344731 | ||
| FWS-R4-ES-2023-0194-0007 | FWS | Receipt of Proposed Habitat Conservation Plan for Scrub-Jay; Aponte, Volusia County, FL; Categorical Exclusion FWS-R4-ES-2023-0194 | Three Incidental Permit Applications and Proposed Habitat Conservation Plans; Lake, Volusia, and Orange Counties, FL; Reopening of Comment Periods | Notice | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-18T05:00:00Z | 2024-01-09T04:59:59Z | 2023-12-18T21:08:17Z | 2023-26977 | 0 | 0 | 0900006486344732 | |
| FWS-R4-ES-2023-0193-0005 | FWS | Receipt of Proposed Habitat Conservation Plan for Sand Skink; Orange County Parks, Orange County, FL; Categorical Exclusion FWS-R4-ES-2023-0193 | Three Incidental Permit Applications and Proposed Habitat Conservation Plans; Lake, Volusia, and Orange Counties, FL; Reopening of Comment Periods | Notice | 2023-12-18T05:00:00Z | 2023 | 12 | 2023-12-18T05:00:00Z | 2024-01-09T04:59:59Z | 2024-01-09T02:01:17Z | 2023-26977 | 0 | 0 | 0900006486344739 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);